Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02897544 · ClinicalTrials.gov registry record · NA

Integrative Approaches for Cancer Survivorship 2: Project 2

A NA study of Breast Cancer, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT02897544 is a NA study of Breast Cancer that has completed, run by University of California, San Francisco. The registered enrollment target is 20 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02897544, a NA study of Breast Cancer, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop and test a 6 month manualized Health Education intervention in recent breast cancer survivors.

Conditions Studied

Interventions

  • BEHAVIORAL Individualized Manualized Health Education Intervention

Study Locations (1)

California

  • University of California, San Francisco, Osher Center for Integrative Medicine - San Francisco

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-09
Est. Completion 2018-06-04
Phase NA

What the Registry Record Tells You About NCT02897544

The ClinicalTrials.gov registry entry for NCT02897544 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Individualized Manualized Health Education Intervention is the first listed.

NCT02897544 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02897544 about?

NCT02897544 is a clinical study titled "Integrative Approaches for Cancer Survivorship 2: Project 2". The purpose of this study is to develop and test a 6 month manualized Health Education intervention in recent breast cancer survivors.

What is the current status of trial NCT02897544?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-09. Estimated completion is 2018-06-04.

What conditions does trial NCT02897544 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02897544?

The interventions under investigation include: Individualized Manualized Health Education Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02897544?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02897544 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.